Healthcare :: Delivering high quality care for all, UK

Delivering the highest quality of care for all, as good or better than any country in the world, must be a fundamental goal of the NHS, said Lord Darzi, as he publishes his interim report on the ‘Our NHS, Our Future’ review.

Head and Neck Cancer :: Taxotere granted FDA approval to treat Head and Neck Cancer

Sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) has approved Taxotere(R) (docetaxel) Injection Concentrate in combination with cisplatin and 5-fluorouracil for induction therapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN) before patients undergo chemoradiotherapy and surgery.

Pharmaceutical :: MIT and Novartis in new partnership aimed at transforming pharmaceutical manufacturing

Novartis and the Massachusetts Institute of Technology have launched a long-term research collaboration aimed at transforming the way pharmaceuticals are produced. The 10-year partnership, known as the Novartis-MIT Center for Continuous Manufacturing, will work to develop new technologies that could replace the conventional batch-based system in the pharmaceuticals industry – which often includes many interruptions and work at separate sites – with continuous manufacturing processes from start to finish.

Contraception :: New male contraceptives successful in humans

Pills, sponges, IUDs, diaphragms– women have many options for planning their fertility, none of them quite perfect. But what if men want to help out? They have only two options — vasectomy, which is usually permanent, and condoms, which are crucial for dating but get old in long-term relationships. Will men ever have a way to reliably make sure that nobody is every calling them “Daddy” before they are ready?

Spirit India